User menu

Cholecystokinin and Neurotensin Injected Into the Ventral Tegmental Area Modulate Concentrations of Dopamine and Metabolites in the Nucleus-accumbens Invivo Using Microdialysis Perfusion

Bibliographic reference De Witte, Philippe ; Laitinen, K. ; Mefford, I. ; Crawley, J.. Cholecystokinin and Neurotensin Injected Into the Ventral Tegmental Area Modulate Concentrations of Dopamine and Metabolites in the Nucleus-accumbens Invivo Using Microdialysis Perfusion.In: Psychopharmacology, Vol. 101, p. S13-S13 (1990)
Permanent URL http://hdl.handle.net/2078.1/63797
  1. Appel J.B., White F.J., Holohean A.M., Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures, 10.1016/0149-7634(82)90036-7
  2. Barry H III (1974) Classification of drugs according to their discriminable effects in rats. Fed Proc 33:1814–1824
  3. Colpaert FC, Slangen JL (eds) (1982) Drug discrimination. Applications in CNS pharmacology. Elsevier/North-Holland Biomedical Press, Amsterdam
  4. Cunningham K. A., Appel J. B., Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD), 10.1007/bf00690929
  5. Cunningham KA, Callahan PM, Appel JB (1984) Discriminative stimulus properties of lergotrile. J Pharmacol Exp Ther 230:47–52
  6. Cunningham KA, Callahan PM, Appel JB (1987) Discriminative stimulus properties of lisuride revisited. Involvement of dopamine D2 receptors. J Pharmacol Exp Ther 241:147–151
  7. Extance K., Goudie A. J., Inter-animal olfactory cues in operant drug discrimination procedures in rats, 10.1007/bf00426467
  8. France CP, Woods JH (1985) Opiate agonist-antagonist interactions. Application of a three-key drug discrimination procedure. J Pharmacol Exp Ther 234:81–89
  9. Honig Werner K., Urcuioli Peter J., The legacy of Guttman and Kalish (1956): Twenty-five years of research on stimulus generalization, 10.1901/jeab.1981.36-405
  10. Jarbe TUC, Swedberg MDB (1982) A conceptualization of drug discrimination learning. In: Colpaert FC, Slangen JL (eds) Drug discrimination. Applications in CNS pharmacology. Elsevier/Biomedical Press, Amsterdam, pp 327–341
  11. Leberer Mark R., Fowler Stephen C., Drug discrimination and generalization in pigeons, 10.1016/0091-3057(77)90219-2
  12. Overton Donald A., Differential responding in a three choice maze controlled by three drug states, 10.1007/bf00404616
  13. Overton DA (1978) Influence of training compartment design on performance in the two-bar drug discrimination task: a methodological report. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier/North Holland Biomedical Press, Amsterdam, pp 265–278
  14. Swedberg Michael D. B., J�rbe Torbj�rn U. C., Drug discrimination procedures: Roles of relative stimulus control in two-drug cases, 10.1007/bf00427906
  15. Swedberg MDB, Jarbe TUC (1986) Drug discrimination procedures: Differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases. Psychopharmacology 90:341–346
  16. White Francis J., Comparative effects of LSD and lisuride: Clues to specific hallucinogenic drug actions, 10.1016/0091-3057(86)90367-9
  17. White Francis J., Appel James B., Training dose as a factor in LSD-saline discrimination, 10.1007/bf00430748
  18. White FJ, Appel JB (1982b) The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. J Pharmacol Exp Ther 221:421–427
  19. White F., Appel J., Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions, 10.1126/science.7071600
  20. White JM, Holtzman SG (1981) Three-choice drug discrimination in the rat: morphine, cyclazocine and saline. J Pharmacol Exp Ther 217:254–262
  21. White Jason M., Holtzman Stephen G., Three-choice drug discrimination: Phencyclidine-like stimulus effects of opioids, 10.1007/bf00427484